RESULT_COUNT: 278,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Announces High Accuracy of Bioinformatics Solutions in Women's Health Genetic Screening,2017-10-19 20:36:00 +0000,https://finance.yahoo.com/news/qiagen-announces-high-accuracy-bioinformatics-203600900.html?.tsrc=rss,"Evaluation of clinical variant interpretation platform presented by Counsyl at ASHG 2017 ORLANDO , GERMANTOWN, Maryland , and HILDEN, Germany , October 19, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN N.V. to Report Third Quarter and First Nine Months of 2017 Results,2017-10-16 10:20:00 +0000,https://finance.yahoo.com/news/qiagen-n-v-report-third-102000087.html?.tsrc=rss,"VENLO, The Netherlands , October 16, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the third quarter and first nine ..."
QGEN,QGEN:UW,BBG000GTZC67,"Exane Asset Management Buys AT&T Inc, Verizon Communications Inc, CNH Industrial NV, Sells ...",2017-10-14 12:15:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qw87DRM0U6I/exane-asset-management-buys-att-inc-verizon-communications-inc-cnh-industrial-nv-sells-cm859800,Exane Asset Management New Purchases CNHI CF UNVR BMRN MRK TWX KITE BA DDC NXTM Added Positions T VZ LBTYA GILD QGEN ASH OLN BIIB SNI BCR Reduced Positions MON GCP FTI BMY DB UBS TSU ALXN TMO PCAR Sold Out CELG AXTA WFC
QGEN,QGEN:UW,BBG000GTZC67,NuVasive's (NUVA) PRECICE System Gets Expanded FDA Approval,2017-10-13 15:18:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xzw76oqJ8aI/nuvasives-nuva-precice-system-gets-expanded-fda-approval-cm859349,NuVasive Inc NUVA has been in the news of late for the receipt of expanded FDA 510 k approval for its advanced magnetic and non invasive limb lengthening technology PRECICE Falling under NuVasive Specialized Orthopedics NSO PRECICE can now be used to treat open and closed
QGEN,QGEN:UW,BBG000GTZC67,Bruker (BRKR) at a 52-Week High: What's Driving the Stock?,2017-10-13 14:18:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mwTrWb75bew/bruker-brkr-at-a-52-week-high-whats-driving-the-stock-cm859378,Bruker Corporation 160 BRKR scaled a new 52 week high of 30 93 on Oct 12 eventually closing a bit lower at 30 71 This Zacks Rank 3 Hold stock has a market cap of 4 88 billion Comparison with Broader Industry For the majority of the last six months the company s share price
QGEN,QGEN:UW,BBG000GTZC67,"Henry Schein Gains on Strategic Buyouts, Cost Concern a Woe",2017-10-13 13:41:01 +0000,https://finance.yahoo.com/news/henry-schein-gains-strategic-buyouts-134101841.html?.tsrc=rss,"Henry Schein (HSIC) continues to grow on dental and animal health business, thanks to merger and acquisition activity. However, rising costs continue to be a burden on the company&apos;s bottom line."
QGEN,QGEN:UW,BBG000GTZC67,NuVasive&apos;s (NUVA) PRECICE System Gets Expanded FDA Approval,2017-10-13 13:03:01 +0000,https://finance.yahoo.com/news/nuvasive-apos-nuva-precice-system-130301926.html?.tsrc=rss,NuVasive&apos;s (NUVA) latest receipt of expanded FDA 510(k) approval for PRECICE is likely to fortify its hold in the limb reconstruction and trauma market.
QGEN,QGEN:UW,BBG000GTZC67,"Abbott Banks on FDA Approvals and Buyouts, Competition Rife",2017-10-13 12:42:12 +0000,https://finance.yahoo.com/news/abbott-banks-fda-approvals-buyouts-124212897.html?.tsrc=rss,The market is upbeat about Abbott&apos;s (ABT) latest initiatives.
QGEN,QGEN:UW,BBG000GTZC67,Bruker (BRKR) at a 52-Week High: What&apos;s Driving the Stock?,2017-10-13 12:41:12 +0000,https://finance.yahoo.com/news/bruker-brkr-52-week-high-124112984.html?.tsrc=rss,"The new 52-week high of Bruker (BRKR) came on the back of several new initiatives, the most recent one being the introduction of the new CE-IVD marked Fungiplex Candida fast diagnostic assay."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Bioinformatics and NGS Solutions Enable Genomic Breakthroughs,2017-10-12 20:05:00 +0000,https://finance.yahoo.com/news/qiagen-bioinformatics-ngs-solutions-enable-200500123.html?.tsrc=rss,"Researchers at ASHG 2017 cite value of QIAGEN Sample to Insight solutions in multiple disease areas HILDEN , Germany and GERMANTOWN, Maryland , October 12, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; ..."
QGEN,QGEN:UW,BBG000GTZC67,"LabCorp (LH) Strong on Strategic Planning, Competition Rife",2017-10-12 13:34:01 +0000,https://finance.yahoo.com/news/labcorp-lh-strong-strategic-planning-133401706.html?.tsrc=rss,LabCorp (LH) grows on strong diagnostics business amid softness in the Covance drug development business.
QGEN,QGEN:UW,BBG000GTZC67,"Henry Schein Closes Merritt Buyout, Expands in Animal Health",2017-10-12 12:48:12 +0000,https://finance.yahoo.com/news/henry-schein-closes-merritt-buyout-124812449.html?.tsrc=rss,Henry Schein (HSIC) is consistently trying to expand its Animal Health business.
QGEN,QGEN:UW,BBG000GTZC67,"CryoLife to Buy JOTEC, Preliminary Revenue Result Out for Q3",2017-10-12 12:47:12 +0000,https://finance.yahoo.com/news/cryolife-buy-jotec-preliminary-revenue-124712137.html?.tsrc=rss,CryoLife (CRY) gained access to the $2-billion global market for stent grafts through JOTEC deal.
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Banks on Tie-Ups & Product Launches, Competition Rife",2017-10-11 16:16:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kTaZr6LIzgo/qiagen-banks-on-tie-ups-product-launches-competition-rife-cm858212,On Oct 10 we issued an updated research report on Netherlands based molecular diagnostics provider 160 QIAGEN QGEN The company offers innovative technologies and products for pre analytical sample preparation and molecular diagnostics solutions We are upbeat about QIAGEN s partnership
QGEN,QGEN:UW,BBG000GTZC67,Is a Beat in Store for Abbott (ABT) This Earnings Season?,2017-10-11 15:18:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PPlua9kumsY/is-a-beat-in-store-for-abbott-abt-this-earnings-season-cm858121,We expect Abbott ABT to surpass expectations when it reports third quarter 2017 results on Oct 18 before the market opens Last quarter Abbott delivered a positive earnings surprise of 3 3 Abbott s strong and impressive earnings track record reflects its estimate beats in each of the
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Banks on Tie-Ups & Product Launches, Competition Rife",2017-10-11 13:55:01 +0000,https://finance.yahoo.com/news/qiagen-banks-tie-ups-product-135501315.html?.tsrc=rss,The market is upbeat about QIAGEN&apos;s (QGEN) partnership and co-marketing agreement with CENTOGENE AG to boost its bioinformatics portfolio.
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Trying To Close In On Key Technical Benchmark,2017-10-11 07:00:00 +0000,http://finance.yahoo.com/r/2f61eafd-f0c8-37dd-a2d4-4f09fc3a0c91/qiagen-trying-to-close-in-on-key-technical-benchmark-2?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Qiagen shows improving technical performance. Will it continue?
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Trying To Close In On Key Technical Benchmark,2017-10-10 15:17:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6tj3P5hxyl8/qiagen-trying-to-close-in-on-key-technical-benchmark-cm857614,On Tuesday Qiagen QGEN got an upgrade to its Relative Strength RS Rating from 67 to 74 ibd display video id 2102289 width 50 float left autostart true IBD s unique RS Rating measures technical performance by using a 1 worst to 99 best score
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Partners With CENTOGENE, Boosts Bioinformatics Suite",2017-10-10 13:34:01 +0000,https://finance.yahoo.com/news/qiagen-partners-centogene-boosts-bioinformatics-133401978.html?.tsrc=rss,"QIAGEN (QGEN) makes another encouraging move to expand its advanced bioinformatics portfolio and add additional capabilities, partners CENTOGENE."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Trying To Close In On Key Technical Benchmark,2017-10-10 07:00:00 +0000,http://finance.yahoo.com/r/076d2426-c174-3e2d-b451-c926233818c4/qiagen-trying-to-close-in-on-key-technical-benchmark?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Qiagen shows improving technical performance. Will it continue?
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and CENTOGENE to Collaborate in Bioinformatics for Genetic Diseases,2017-10-09 20:05:00 +0000,https://finance.yahoo.com/news/qiagen-centogene-collaborate-bioinformatics-genetic-200500888.html?.tsrc=rss,"Aiding the analysis of hereditary disorders by integrating genomic and clinical databases HILDEN and ROSTOCK , Germany and GERMANTOWN, Maryland , October 9, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt ..."
QGEN,QGEN:UW,BBG000GTZC67,"ETFs with exposure to QIAGEN NV : October 9, 2017",2017-10-09 15:58:29 +0000,http://finance.yahoo.com/r/c751cd79-f91a-35c0-893d-b73301fc85e5/etfs-with-exposure-to-qiagen-nv-october-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to QIAGEN NV Here are 5 ETFs with the largest exposure to QGEN-US. Comparing the performance and risk of QIAGEN NV with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's QFT-Plus Launch to Boost Molecular Diagnostics Arm,2017-10-06 15:47:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kAxFZShN_VI/qiagens-qft-plus-launch-to-boost-molecular-diagnostics-arm-cm856230,Post the receipt of FDA approval in June QIAGEN 160 QGEN recently announced the complete launch of the fourth generation of its blood test for tuberculosis TB infection QuantiFERON TB Gold Plus QFT Plus in the United States The advanced test kit will be available from Oct 9 Built
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN&apos;s QFT-Plus Launch to Boost Molecular Diagnostics Arm,2017-10-06 13:33:01 +0000,https://finance.yahoo.com/news/qiagen-apos-qft-plus-launch-133301219.html?.tsrc=rss,QIAGEN (QGEN) strengthens its highest revenue grossing segment with the launch of QuantiFERON-TB Gold Plus in the United States.
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017",2017-10-06 13:04:00 +0000,http://finance.yahoo.com/r/b863b259-9d16-382b-a2d5-ac39ed7d9505/qiagen-nv-qgen-us-earnings-analysis-q2-2017-by-the-numbers-october-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis QIAGEN NV reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 348.99 million, Net Earnings of USD 13.95 million. Gross margins widened from 54.66% to 64.52% compared to the same period last year, operating (EBITDA) margins now 33.14% from 24.51%. Change in operating cash ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches Fourth-generation QuantiFERON®-TB Gold Plus in the U.S.,2017-10-05 20:05:00 +0000,https://finance.yahoo.com/news/qiagen-launches-fourth-generation-quantiferon-200500558.html?.tsrc=rss,"Novel CD4/CD8 design delivers most comprehensive evaluation of patients' immune response to tuberculosis infection GERMANTOWN, Maryland and HILDEN, Germany , October 5, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Achieves ISO Certification for State-of-the-art Quality in Forensics,2017-10-02 20:05:00 +0000,https://finance.yahoo.com/news/qiagen-achieves-iso-certification-state-200500167.html?.tsrc=rss,"Assuring the highest accuracy in human identity testing for law enforcement and other uses HILDEN , Germany and GERMANTOWN, Maryland , October 2, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Reaches Analyst Target Price,2017-09-26 13:51:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3fTerwDJZik/qiagen-reaches-analyst-target-price-cm850926,In recent trading shares of Qiagen NV Symbol QGEN have crossed above the average analyst 12 month target price of 32 75 changing hands for 32 83 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation or re adjust
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : September 26, 2017",2017-09-26 12:12:50 +0000,http://finance.yahoo.com/r/f69554bf-c784-3ca3-b6e6-cd5d5d869d9c/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-september-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for QIAGEN NV. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,See what the IHS Markit Score report has to say about Qiagen NV.,2017-09-12 12:02:08 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120208528.html?.tsrc=rss,Qiagen NV NASDAQ/NGS:QGEN
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer,2017-08-21 20:10:00 +0000,https://finance.yahoo.com/news/qiagen-clinical-genomics-partner-liquid-201000460.html?.tsrc=rss,"HILDEN, Germany and GERMANTOWN, Md. and BRIDGEWATER, N.J., Aug. 21, 2017-- QIAGEN and Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and Clinical Genomics Partner on Liquid Biopsies to Monitor Patients for Recurrence of Colorectal Cancer,2017-08-21 20:05:00 +0000,https://finance.yahoo.com/news/qiagen-clinical-genomics-partner-liquid-200500298.html?.tsrc=rss,"Convenient blood test uses novel technology to test for recurrence of tumors by detecting circulating DNA HILDEN , Germany , GERMANTOWN, Maryland and BRIDGEWATER, New Jersey , August 21, 2017 /PRNewswire/ ..."
QGEN,QGEN:UW,BBG000GTZC67,See what the IHS Markit Score report has to say about Qiagen NV.,2017-08-17 12:07:05 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120628268.html?.tsrc=rss,Qiagen NV NASDAQ/NGS:QGEN
QGEN,QGEN:UW,BBG000GTZC67,Abbott-North West London Pathology Expand in Diagnostics,2017-08-16 15:39:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jmW0iyBpnC8/abbott-north-west-london-pathology-expand-in-diagnostics-cm832778,Illinois based global medical device company Abbott Laboratories ABT recently signed a 252 million managed equipment service contract with North West London Pathology NWLP hosted by Imperial College Healthcare NHS Trust Abbott expects this alliance to solidify its footprint in the
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV – Value Analysis (NASDAQ:QGEN) : August 14, 2017",2017-08-14 22:08:39 +0000,http://finance.yahoo.com/r/5bf92687-29f5-3903-a2d6-e0fdf3ddb274/qiagen-nv-value-analysis-nasdaqqgen-august-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives QIAGEN NV a score of 44. Our analysis is based on comparing QIAGEN NV with the following peers – Thermo Fisher Scientific Inc., Genomic Health, Inc., Hologic, Inc., Becton, Dickinson and Company, General Electric Company, Trovagene, Inc., Bio-Techne Corporation and GenMark Diagnostics, Inc. (TMO-US, GHDX-US, HOLX-US, BDX-US, ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,Edited Transcript of QGEN earnings conference call or presentation 28-Jul-17 1:00pm GMT,2017-08-12 06:51:15 +0000,https://finance.yahoo.com/news/edited-transcript-qgen-earnings-conference-214132986.html?.tsrc=rss,Q2 2017 Qiagen NV Earnings Call
QGEN,QGEN:UW,BBG000GTZC67,See what the IHS Markit Score report has to say about Qiagen NV.,2017-08-11 12:01:56 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120156014.html?.tsrc=rss,Qiagen NV NASDAQ/NGS:QGEN
QGEN,QGEN:UW,BBG000GTZC67,See what the IHS Markit Score report has to say about Qiagen NV.,2017-08-10 12:01:58 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120158514.html?.tsrc=rss,Qiagen NV NASDAQ/NGS:QGEN
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Enters Oversold Territory (QGEN),2017-08-03 18:02:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K6IDPACchKk/qiagen-enters-oversold-territory-qgen-cm826697,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
QGEN,QGEN:UW,BBG000GTZC67,"A Beat From Qiagen NV, but Only Half a Raise",2017-07-31 18:55:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VsieCSFnkQ0/a-beat-from-qiagen-nv-but-only-half-a-raise-cm824448,It was another solid quarter 160 for Qiagen NASDAQ QGEN as the maker of diagnostic and scientific products continues to post decent revenue growth while getting more efficient which drives income to grow even faster QIAsymphony Image source Qiagen
QGEN,QGEN:UW,BBG000GTZC67,"A Beat From Qiagen NV, but Only Half a Raise",2017-07-31 16:49:00 +0000,http://finance.yahoo.com/r/ab141cb2-97de-36b2-9644-e0d2fb7048b1/a-beat-from-qiagen-nv-but-only-half-a-raise.aspx?yptr=yahoo&.tsrc=rss,"After a solid quarter, management raises 2017 revenue guidance but leaves earnings guidance intact."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 31, 2017",2017-07-31 14:03:33 +0000,http://finance.yahoo.com/r/be508e0a-b8d5-3c7f-b012-fc4ce63aafd9/qiagen-nv-breached-its-50-day-moving-average-in-a-bearish-manner-qgen-us-july-31-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for QIAGEN NV. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Beats on Earnings & Sales in Q2, Raises View",2017-07-28 15:02:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uaIUMs9VG-I/qiagen-qgen-beats-on-earnings-sales-in-q2-raises-view-cm823313,QIAGEN 160 N V 160 QGEN reported second quarter 2017 adjusted earnings per share considering restructuring expenses as one time item of 30 cents up 25 year over year The reported figure beat the Zacks Consensus Estimate by a penny At constant exchange rate or CER the company
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Beats on Earnings & Sales in Q2, Raises View",2017-07-28 13:46:01 +0000,https://finance.yahoo.com/news/qiagen-qgen-beats-earnings-sales-134601375.html?.tsrc=rss,QIAGEN (QGEN) continues to bank on the Molecular Diagnostics space for growth.
QGEN,QGEN:UW,BBG000GTZC67,Qiagen beats Street 2Q forecasts,2017-07-27 21:46:28 +0000,https://finance.yahoo.com/news/qiagen-beats-street-2q-forecasts-155029808.html?.tsrc=rss,"The Venlo, Netherlands-based company said it had profit of 6 cents per share. Earnings, adjusted for non-recurring costs, came to 30 cents per share. The results exceeded Wall Street expectations. The ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reports Results for Second Quarter and First Half of 2017,2017-07-27 15:16:00 +0000,https://finance.yahoo.com/news/qiagen-reports-results-second-quarter-151600421.html?.tsrc=rss,"VENLO, Netherlands , July 27, 2017 /PRNewswire/ -- Strong Q2 2017 results reaffirm QIAGEN on track to achieve full-year goals :   Net sales $3 49.0 million (+ 4 % actual); a djusted net sales $3 49 . 6 ..."
QGEN,QGEN:UW,BBG000GTZC67,InPlay from Briefing.com,2017-07-27 13:57:10 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
QGEN,QGEN:UW,BBG000GTZC67,HTG Molecular Diagnostics Announces Second Companion Diagnostic Development Project with QIAGEN,2017-07-27 13:00:00 +0000,https://finance.yahoo.com/news/htg-molecular-diagnostics-announces-second-130000086.html?.tsrc=rss,"TUCSON, Ariz. and VENLO, the Netherlands, July 27, 2017-- HTG Molecular Diagnostics, Inc., a provider of instruments, reagents and services for molecular profiling applications today announced the initiation ..."
QGEN,QGEN:UW,BBG000GTZC67,"Exane Asset Management Buys Monsanto Co, Biogen Inc, Qiagen NV, Sells Citigroup Inc, W R Grace, ...",2017-07-20 10:02:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o47GE0W7INw/exane-asset-management-buys-monsanto-co-biogen-inc-qiagen-nv-sells-citigroup-inc-w-r-grace-cm818454,Exane Asset Management New Purchases MON BIIB BAC ALXN OLN NXPI LBTYA WOOF MBLY VWR Added Positions QGEN ASH FTI GILD DB BMY PCAR DBVT SU HAL Reduced Positions C UBS WFC TSU APD HES TMUS AXTA APC CLR Sold Out GRA WLK
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN N.V. to Report Second Quarter and First Half of 2017 Results,2017-07-13 08:02:00 +0000,https://finance.yahoo.com/news/qiagen-n-v-report-second-080200613.html?.tsrc=rss,"VENLO, Netherlands, July 13, 2017 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of 2017 ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 7, 2017",2017-07-07 13:43:32 +0000,http://finance.yahoo.com/r/12c6f0b4-0f21-3be7-8c76-ffbe67c6d51b/qiagen-nv-breached-its-50-day-moving-average-in-a-bearish-manner-qgen-us-july-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for QIAGEN NV. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"ETFs with exposure to QIAGEN NV : July 5, 2017",2017-07-05 17:07:17 +0000,http://finance.yahoo.com/r/c391c095-1cc1-3cc8-a02a-a7e234aae54e/etfs-with-exposure-to-qiagen-nv-july-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to QIAGEN NV Here are 5 ETFs with the largest exposure to QGEN-US. Comparing the performance and risk of QIAGEN NV with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"ETFs with exposure to QIAGEN NV : June 22, 2017",2017-06-22 20:18:03 +0000,http://finance.yahoo.com/r/86bc6801-29b4-3d84-aa96-2cedd683692c/etfs-with-exposure-to-qiagen-nv-june-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to QIAGEN NV Here are 5 ETFs with the largest exposure to QGEN-US. Comparing the performance and risk of QIAGEN NV with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test,2017-06-22 12:04:00 +0000,https://finance.yahoo.com/news/french-health-system-approves-reimbursement-120400390.html?.tsrc=rss,"Gold standard test for latent tuberculosis infection will be covered by national health insurance HILDEN , Germany , and PARIS , June 22, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017",2017-06-16 16:01:58 +0000,http://finance.yahoo.com/r/23d08e28-2a8f-3f26-8200-30ffae02ca6e/qiagen-nv-qgen-us-earnings-analysis-q1-2017-by-the-numbers-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis QIAGEN NV reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of QIAGEN NV – Thermo Fisher Scientific Inc., Genomic Health, Inc., Hologic, Inc., Becton, Dickinson and Company, General Electric Company, Trovagene, Inc., Bio-Techne Corporation and GenMark Diagnostics, Inc. (TMO-US, GHDX-US, ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"ADMP Soars On FDA Nod, It Is Advantage OXFD, LLY In Good Spirits",2017-06-15 22:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0co6saDS3KE/admp-soars-on-fda-nod-it-is-advantage-oxfd-lly-in-good-spirits-20170615-01389,"ADMP Soars On FDA Nod, It Is Advantage OXFD, LLY In Good Spirits"
QGEN,QGEN:UW,BBG000GTZC67,"Noteworthy ETF Outflows: PBE, QGEN, IONS, ALXN",2017-06-09 16:27:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FY_BpqekmeM/noteworthy-etf-outflows-pbe-qgen-ions-alxn-cm801241,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the PowerShares Dynamic Biotechnology amp Genome Portfolio Symbol PBE where we have detected an approximate 69 7 million dollar outflow that s a 23 4
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval,2017-06-08 13:00:00 +0000,https://finance.yahoo.com/news/qiagens-quantiferon-tb-gold-plus-130000537.html?.tsrc=rss,"GERMANTOWN, Md. and HILDEN, Germany, June 8, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON ® -TB Gold Plus ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Strengthens Cancer Research Foothold on New License,2017-06-06 14:06:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_PzkCzjcMtE/qiagen-strengthens-cancer-research-foothold-on-new-license-cm799201,QIAGEN N V QGEN a molecular diagnostic company has recently got a scope to broaden its range of biomarker content The company has received a worldwide license for biomarkers to be used in identifying patients who may have benefitted from immune oncology I O therapies in cancer
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Strengthens Cancer Research Foothold on New License,2017-06-06 11:28:11 +0000,https://finance.yahoo.com/news/qiagen-strengthens-cancer-research-foothold-112811754.html?.tsrc=rss,QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform,2017-06-06 06:00:00 +0000,https://finance.yahoo.com/news/qiagen-receives-u-fda-approval-060000113.html?.tsrc=rss,"GERMANTOWN, Md. and HILDEN, Germany, June 6, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received premarket approval from the U.S. Food and Drug Administration ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN: FDA Approves Cytomegalovirus Testing On Automated QIAsymphony Platform,2017-06-06 02:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/74W1cvDnwjw/qiagen-fda-approves-cytomegalovirus-testing-on-automated-qiasymphony-platform-20170606-00054,QIAGEN: FDA Approves Cytomegalovirus Testing On Automated QIAsymphony Platform
QGEN,QGEN:UW,BBG000GTZC67,Bristol-Myers Presents Data on Immuno-Oncology Drug Opdivo,2017-06-05 23:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yTj6QAVOWsE/bristol-myers-presents-data-on-immuno-oncology-drug-opdivo-cm799033,Bristol Myers Squibb Company BMY announced that the European Commission EC has approved immuno oncology drug Opdivo for the treatment of locally advanced unresectable or metastatic urothelial carcinoma mUC in adults after failure of prior platinum containing therapy Opdivo is approved
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN & Bristol-Myers Squibb Partner on Cancer Research,2017-06-05 17:04:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eKCF3dTtHf8/qiagen-bristol-myers-squibb-partner-on-cancer-research-cm798824,Leading life science research company QIAGEN N V QGEN has made significant advancement in the field of cancer research through the use of its revolutionary next generation sequencing NGS technology The company recently collaborated with global biopharmaceutical company Bristol Myers
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN & Bristol-Myers Squibb Partner on Cancer Research,2017-06-05 14:28:02 +0000,https://finance.yahoo.com/news/qiagen-bristol-myers-squibb-partner-142802603.html?.tsrc=rss,QIAGEN N.V. (QGEN) has made significant advancement in the field of cancer research through the use of its revolutionary next-generation sequencing (NGS) technology.
QGEN,QGEN:UW,BBG000GTZC67,Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies,2017-06-03 17:00:00 +0000,https://finance.yahoo.com/news/bristol-myers-squibb-qiagen-sign-170000115.html?.tsrc=rss,Bristol-Myers Squibb Company and QIAGEN have signed an agreement to explore the use of next-generation sequencing technology to develop gene expression profiles as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology therapies in cancer treatment.
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies,2017-06-03 17:00:00 +0000,https://finance.yahoo.com/news/qiagen-expands-biomarker-content-portfolio-170000523.html?.tsrc=rss,"HILDEN, Germany and GERMANTOWN, Md., June 3, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University ..."
QGEN,QGEN:UW,BBG000GTZC67,3 Top Gene-Sequencing Stocks Poised for Solid Growth,2017-05-31 23:33:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fVJ7CPRH9r4/3-top-gene-sequencing-stocks-poised-for-solid-growth-cm797160,Gene sequencing technology that enabled mapping the human genome has also opened up tremendous possibilities in genetic testing and precision medicine It s also created plenty of DNA plays in investing with stocks such as Illumina NASDAQ ILMN soaring over the past
QGEN,QGEN:UW,BBG000GTZC67,3 Top Gene-Sequencing Stocks Poised for Solid Growth,2017-05-31 20:42:00 +0000,http://finance.yahoo.com/r/05285e56-217b-35a7-9026-2900bfb46340/3-top-gene-sequencing-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Why Illumina, Qiagen, and Thermo Fisher Scientific rank as top gene-sequencing stocks you can buy now."
QGEN,QGEN:UW,BBG000GTZC67,Edited Transcript of QGEN earnings conference call or presentation 3-May-17 1:00pm GMT,2017-05-12 00:46:07 +0000,http://finance.yahoo.com/news/edited-transcript-qgen-earnings-conference-124543823.html?.tsrc=rss,Q1 2017 Qiagen NV Earnings Call
QGEN,QGEN:UW,BBG000GTZC67,Blog Coverage: INC Research Holdings Acquires Privately Held inVentiv Health,2017-05-11 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-inc-research-holdings-121500545.html?.tsrc=rss,"Upcoming AWS Coverage on QIAGEN Post-Earnings Results LONDON, UK / ACCESSWIRE / May 11, 2017 / Active Wall St. blog coverage looks at the headline from Raleigh, North Carolina based INC Research Holdings, ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Banks on Molecular Diagnostic amid Currency Woes,2017-05-08 15:03:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q9vKwubn8b4/qiagen-banks-on-molecular-diagnostic-amid-currency-woes-cm785805,On May 4 we issued an updated research report on leading molecular diagnostic company Qiagen N V QGEN The stock currently has a Zacks Rank 3 Hold In the last three months QIAGEN was trading below the Zacks categorized Medical Biomedical and Genetics industry until it released
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Banks on Molecular Diagnostic amid Currency Woes,2017-05-08 13:47:01 +0000,http://finance.yahoo.com/news/qiagen-banks-molecular-diagnostic-amid-134701244.html?.tsrc=rss,"On May 4, we issued an updated research report on leading molecular diagnostic company, Qiagen N.V. (QGEN)."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN NV's Getting It Done,2017-05-04 20:12:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DD9RNweySC8/qiagen-nvs-getting-it-done-cm784512,Qiagen NASDAQ QGEN reported first quarter earnings on Tuesday afternoon with revenue growth beating guidance and adjusted earnings coming at the high end of the range Qiagen results The raw numbers Metric Q1
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN NV&apos;s Getting It Done,2017-05-04 18:40:00 +0000,http://finance.yahoo.com/r/3aec975d-5f67-3385-b2bc-3fa54547d5b6/qiagen-nvs-getting-it-done.aspx?yptr=yahoo&.tsrc=rss,First-quarter results meet or exceed expectations. Can&apos;t ask for more than that.
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Beats Q1 Earnings Estimates, Retains View",2017-05-03 19:54:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2sQH9qoaHqw/qiagen-qgen-beats-q1-earnings-estimates-retains-view-cm783747,QIAGEN 160 N V 160 QGEN reported first quarter 2017 adjusted earnings per share considering restructuring expenses as one time item of 22 cents up 15 8 year over year The reported figure was ahead of the Zacks Consensus Estimate by a penny At constant exchange rate or CER the
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Beats Q1 Earnings Estimates, Retains View",2017-05-03 13:40:01 +0000,http://finance.yahoo.com/news/qiagen-qgen-beats-q1-earnings-134001669.html?.tsrc=rss,"QIAGEN N.V. (QGEN) reported first-quarter 2017 adjusted earnings per share (considering restructuring expenses as one time item) of 22 cents, up 15.8% year over year."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen beats Street 1Q forecasts,2017-05-02 23:07:41 +0000,http://finance.yahoo.com/news/qiagen-beats-street-1q-forecasts-230741001.html?.tsrc=rss,"The Venlo, Netherlands-based company said it had net income of 8 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were 22 cents per share. The results exceeded Wall Street ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reports Results for First Quarter 2017,2017-05-02 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-reports-results-first-quarter-200500149.html?.tsrc=rss,"VENLO, the Netherlands, May 2, 2017 /PRNewswire/ -- Delivering on growth ambitions with good Q1 2017 performance:     o   Net sales $307.7 million (+3% actual); a djusted net sales $308.3 million (+3% ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Partners With Maccura to Localize and Commercialize GeneReader NGS System in China,2017-05-02 06:00:00 +0000,http://finance.yahoo.com/news/qiagen-partners-maccura-localize-commercialize-060000996.html?.tsrc=rss,"HILDEN, Germany, and CHENGDU, China, May 2, 2017 /PRNewswire/ -- Partnership with a leading Chinese IVD company with goal to accelerate penetration of the world ' s first complete Sample to Insight NGS ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV – Value Analysis (NASDAQ:QGEN) : April 26, 2017",2017-04-26 20:30:12 +0000,http://finance.yahoo.com/r/95e83ea8-6f2c-3a88-8984-9602a5370ec4/qiagen-nv-value-analysis-nasdaqqgen-april-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives QIAGEN NV a score of 38. Our analysis is based on comparing QIAGEN NV with the following peers – Thermo Fisher Scientific Inc., Genomic Health, Inc., Hologic, Inc., Becton, Dickinson and Company, General Electric Company, Trovagene, Inc., Bio-Techne Corporation and GenMark Diagnostics, Inc. (TMO-US, GHDX-US, HOLX-US, BDX-US, ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : April 25, 2017",2017-04-25 13:03:04 +0000,http://finance.yahoo.com/r/307190db-9264-3f6e-99cb-36111d2bad9d/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-april-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for QIAGEN NV. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,The Top Gene-Sequencing Stock to Buy in 2017,2017-04-20 22:04:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GJ5rBTQ7UIo/the-top-gene-sequencing-stock-to-buy-in-2017-cm776744,Investors have fairly limited options for buying gene sequencing companies there just aren t that many to invest in And some of the companies involved in gene sequencing aren t exclusively focused on it But one company stands out
QGEN,QGEN:UW,BBG000GTZC67,The Top Gene-Sequencing Stock to Buy in 2017,2017-04-20 20:20:00 +0000,http://finance.yahoo.com/r/a7a8c34a-2551-3111-8d54-f8bf65aacb67/the-top-gene-sequencing-stock-to-buy-in-2017.aspx?yptr=yahoo&.tsrc=rss,Illumina is investors&apos; best buy in this category.
QGEN,QGEN:UW,BBG000GTZC67,New Research Suggests Potential for Additional Clinical Utility of QIAGEN's QuantiFERON-TB Gold Plus,2017-04-12 20:05:00 +0000,http://finance.yahoo.com/news/research-suggests-potential-additional-clinical-200500314.html?.tsrc=rss,"HILDEN, Germany, and GERMANTOWN, Maryland, April 12, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that two peer-reviewed studies indicate the potential ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen (QGEN) Down 2.6% Since Earnings Report: Can It Rebound?,2017-04-12 12:55:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7NG5SdCX3GY/qiagen-qgen-down-26-since-earnings-report-can-it-rebound-cm773071,It has been about a month since the last earnings report for Qiagen N V QGEN Shares have lost about 2 6 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
QGEN,QGEN:UW,BBG000GTZC67,Qiagen (QGEN) Down 2.6% Since Earnings Report: Can It Rebound?,2017-04-12 11:00:11 +0000,http://finance.yahoo.com/news/qiagen-qgen-down-2-6-110011428.html?.tsrc=rss,Qiagen (QGEN) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Posts 2016 Annual Report on its Website,2017-04-06 16:15:00 +0000,http://finance.yahoo.com/news/qiagen-posts-2016-annual-report-161500672.html?.tsrc=rss,"VENLO, the Netherlands, April 6, 2017 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) has posted its 2016 Annual Report on its website at http://www.qiagen.com/About-Us/Investors/Financial-Information/Financial-Reports ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN N.V. to Report First Quarter 2017 Results,2017-04-06 13:15:00 +0000,http://finance.yahoo.com/news/qiagen-n-v-report-first-131500330.html?.tsrc=rss,"VENLO, Netherlands, April 6, 2017 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans to release its report on results for the first quarter of 2017 on Tuesday, May 2, at approximately 22:00 ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Releases Favorable GeneReader Results, Expands in NGS",2017-04-04 17:26:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MjDJ6XXnXlA/qiagen-releases-favorable-genereader-results-expands-in-ngs-cm769683,The Netherlands based QIAGEN N V QGEN a global provider of Sample to Insight solutions recently validated its GeneReader NGS System and published five new independent studies based on it at the Global Congress on Molecular Pathology in Berlin We believe the favorable outcome will fortify
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Releases Favorable GeneReader Results, Expands in NGS",2017-04-04 15:12:03 +0000,http://finance.yahoo.com/news/qiagen-releases-favorable-genereader-results-151203323.html?.tsrc=rss,QIAGEN N.V. (QGEN) recently has validated its GeneReader NGS System and published five new independent studies.
QGEN,QGEN:UW,BBG000GTZC67,4:16 am Qiagen presents independent studies that reaffirm the analytical performance of co's GeneReader NGS System,2017-04-03 08:16:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#qgen,4:16 am Qiagen presents independent studies that reaffirm the analytical performance of co's GeneReader NGS System
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's GeneReader NGS System Gains Further Validation in Oncology Research Applications With New Independent Performance Review Data,2017-04-03 06:00:00 +0000,http://finance.yahoo.com/news/qiagens-genereader-ngs-system-gains-060000843.html?.tsrc=rss,"HILDEN, Germany, April 3, 2017 /PRNewswire/ -- Studies presented at AMP Global conference in Berlin reaffirm powerful analytical performance and ease of use for the world's first complete Sample to Insight ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's GeneReader NGS System Gains Further Validation in Oncology Research Applications With New Independent Performance Review Data,2017-04-03 06:00:00 +0000,http://finance.yahoo.com/news/qiagens-genereader-ngs-system-gains-060000843.html,"[PR Newswire] - HILDEN, Germany, April 3, 2017 /PRNewswire/ -- Studies presented at AMP Global conference in Berlin reaffirm powerful analytical performance and ease of use for the world's first complete Sample to Insight ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer,2017-03-31 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-expands-liquid-biopsy-pipeline-200500017.html?.tsrc=rss,"HILDEN, Germany and GERMANTOWN, Maryland, March 31, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it is commercializing the Research use only AdnaTest Prostate ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer,2017-03-31 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-expands-liquid-biopsy-pipeline-200500017.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, March 31, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it is commercializing the Research use only AdnaTest Prostate ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows,2017-03-30 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-joins-cancer-id-consortium-200500033.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, March 30, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has joined CANCER-ID, a public-private consortium aiming ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows,2017-03-30 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-joins-cancer-id-consortium-200500033.html?.tsrc=rss,"HILDEN, Germany and GERMANTOWN, Maryland, March 30, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has joined CANCER-ID, a public-private consortium aiming ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics",2017-03-30 15:04:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQg2Jg8jVvE/qiagen-offers-jak2-kit-in-us-grows-in-molecular-diagnostics-cm767685,Sample and assay technologies provider QIAGEN N V QGEN launched ipsogen JAK2 RGQ PCR Kit in the U S following the Food and Drug Administration s FDA approval This assay is the First FDA approved JAK2 Kit which will act as a qualitative in vitro diagnostic test for the detection of the
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics",2017-03-30 12:49:12 +0000,http://finance.yahoo.com/news/qiagen-offers-jak2-kit-us-124912122.html,"QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics",2017-03-30 12:49:12 +0000,http://finance.yahoo.com/news/qiagen-offers-jak2-kit-us-124912122.html?.tsrc=rss,"QIAGEN N.V. (QGEN) launched ipsogen JAK2 RGQ PCR Kit in the U.S, following the Food and Drug Administration's (FDA) approval."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches First FDA-cleared JAK2 Test for Certain Type of Leukemia,2017-03-29 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-launches-first-fda-cleared-200500625.html,"[PR Newswire] - GERMANTOWN, Maryland, and HILDEN, Germany, March 29, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; FRANKFURT PRIME STANDARD: QIA) today announced the U.S. launch of its ipsogen ® JAK2 RGQ PCR Kit ( ipsogen ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches First FDA-cleared JAK2 Test for Certain Type of Leukemia,2017-03-29 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-launches-first-fda-cleared-200500625.html?.tsrc=rss,"GERMANTOWN, Maryland, and HILDEN, Germany, March 29, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; FRANKFURT PRIME STANDARD: QIA) today announced the U.S. launch of its ipsogen ® JAK2 RGQ PCR Kit ( ipsogen ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 28, 2017",2017-03-28 12:09:11 +0000,http://finance.yahoo.com/r/a4c0412f-da20-361c-9768-72e4cb561d3b/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-march-28-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for QIAGEN NV. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 28, 2017",2017-03-28 12:09:11 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-march-28-2017/,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 28, 2017"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN NV Financials,2017-03-09 18:04:08 +0000,http://finance.yahoo.com/q/is?s=qgen&annual,QIAGEN NV Financials
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 6, 2017",2017-03-06 12:54:40 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-march-6-2017/,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : March 6, 2017"
QGEN,QGEN:UW,BBG000GTZC67,New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants,2017-02-16 07:20:00 +0000,http://finance.yahoo.com/news/study-published-lancet-respiratory-medicine-072000555.html?.tsrc=rss,"HILDEN, Germany and GERMANTOWN, Maryland, February 16, 2017 /PRNewswire/ -- Results Suggest Benefits of Quantitative Screening of Young Children in Countries With High TB Burden   QIAGEN N.V. (NASDAQ: ..."
QGEN,QGEN:UW,BBG000GTZC67,New Study Published in Lancet Respiratory Medicine Highlights QIAGEN's QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants,2017-02-16 07:20:00 +0000,http://finance.yahoo.com/news/study-published-lancet-respiratory-medicine-072000555.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, February 16, 2017 /PRNewswire/ -- Results Suggest Benefits of Quantitative Screening of Young Children in Countries With High TB Burden QIAGEN N.V. (NASDAQ: ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017",2017-02-08 16:31:19 +0000,http://finance.yahoo.com/r/6c2c1491-f627-3c27-9ece-7614ef42a3bc/qiagen-nv-qgen-us-earnings-analysis-2016-by-the-numbers-february-8-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis QIAGEN NV reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of QIAGEN NV – Thermo Fisher Scientific Inc., Hologic, Inc., Becton, Dickinson and Company and General Electric Company (TMO-US, HOLX-US, BDX-US and GE-US) that have also reported for this period. ... Read more    
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017",2017-02-08 16:31:19 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-qgen-us-earnings-analysis-2016-by-the-numbers-february-8-2017/,"QIAGEN NV :QGEN-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017",2017-02-06 16:51:56 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-qgen-us-earnings-analysis-q4-2016-by-the-numbers-february-6-2017/,"QIAGEN NV :QGEN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4",2017-02-03 14:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wl4HDsYK6ew/qiagen-qgen-earnings-meet-sales-miss-estimates-in-q4-cm742716,QIAGEN 160 N V QGEN reported fourth quarter 2016 adjusted earnings per share excluding restructuring expenses of 39 cents up 7 7 year over year The reported earnings figure is in line with the Zacks Consensus Estimate At constant exchange rate or CER too the company reported
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4",2017-02-03 12:23:12 +0000,http://finance.yahoo.com/news/qiagen-qgen-earnings-meet-sales-122312030.html?.tsrc=rss,"QIAGEN N.V. (QGEN) reported fourth-quarter 2016 adjusted earnings per share (excluding restructuring expenses) of 39 cents, up 7.7% year over year."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4",2017-02-03 12:23:12 +0000,http://finance.yahoo.com/news/qiagen-qgen-earnings-meet-sales-122312030.html,"QIAGEN (QGEN) Earnings Meet, Sales Miss Estimates in Q4"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN NV Continues Its Turnaround,2017-02-02 22:33:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pjrAqZbDZME/qiagen-nv-continues-its-turnaround-cm742516,Qiagen NASDAQ QGEN continued its turnaround with new products overshadowing falling U S HPV test sales in the fourth quarter and a nice increase in earnings at least on an adjusted basis Image source Qiagen Qiagen results The raw
QGEN,QGEN:UW,BBG000GTZC67,Edited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT,2017-02-02 22:29:48 +0000,http://finance.yahoo.com/news/edited-transcript-qgen-earnings-conference-222948003.html?.tsrc=rss,Q4 2016 Qiagen NV Earnings Call
QGEN,QGEN:UW,BBG000GTZC67,Edited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT,2017-02-02 22:29:48 +0000,http://finance.yahoo.com/news/edited-transcript-qgen-earnings-conference-222948003.html,Edited Transcript of QGEN earnings conference call or presentation 2-Feb-17 2:00pm GMT
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN NV Continues Its Turnaround,2017-02-02 21:16:14 +0000,http://www.fool.com/investing/2017/02/02/qiagen-nv-continues-its-turnaround.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,QIAGEN NV Continues Its Turnaround
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN NV Continues Its Turnaround,2017-02-02 21:16:14 +0000,http://finance.yahoo.com/r/b101ca9c-87fb-3668-87e8-3d237bc52731/qiagen-nv-continues-its-turnaround.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss,Newer products help boost the top line.
QGEN,QGEN:UW,BBG000GTZC67,Qiagen NV Q4 16 Earnings Conference Call At 9:30 AM ET,2017-02-02 08:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6qxUAGp5oA/qiagen-nv-q4-16-earnings-conference-call-at-930-am-et-20170202-00740,Qiagen NV Q4 16 Earnings Conference Call At 9:30 AM ET
QGEN,QGEN:UW,BBG000GTZC67,Qiagen meets 4Q profit forecasts,2017-02-01 23:18:36 +0000,http://finance.yahoo.com/news/qiagen-meets-4q-profit-forecasts-231836796.html?.tsrc=rss,"On a per-share basis, the Venlo, Netherlands-based company said it had profit of 4 cents. Earnings, adjusted for non-recurring costs, were 39 cents per share. The results matched Wall Street expectations. ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen meets 4Q profit forecasts,2017-02-01 23:18:36 +0000,http://sg.finance.yahoo.com/news/qiagen-meets-4q-profit-forecasts-231836479.html,Qiagen meets 4Q profit forecasts
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reports Results for Fourth Quarter and Full-year 2016,2017-02-01 21:05:00 +0000,http://finance.yahoo.com/news/qiagen-reports-results-fourth-quarter-210500591.html,"[PR Newswire] - VENLO, the Netherlands, February 1, 2017 /PRNewswire/ -- Ongoing momentum in fourth quarter supports strong 2016 performance: ● Q4 2016: - Net sales $366.5 million (+5% actual, +8% CER vs. +8% CER ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reports Results for Fourth Quarter and Full-year 2016,2017-02-01 21:05:00 +0000,http://finance.yahoo.com/news/qiagen-reports-results-fourth-quarter-210500591.html?.tsrc=rss,"VENLO, the Netherlands, February 1, 2017 /PRNewswire/ -- Ongoing momentum in fourth quarter supports strong 2016 performance:   ●  Q4 2016:     - Net sales $366.5 million (+5% actual, +8% CER vs. +8% CER ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reaffirms 2017 Outlook - Quick Facts,2017-02-01 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JUR9NTInmSM/qiagen-reaffirms-2017-outlook--quick-facts-20170201-01651,QIAGEN Reaffirms 2017 Outlook - Quick Facts
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : February 1, 2017",2017-02-01 12:36:43 +0000,http://finance.yahoo.com/r/75cd7c04-0a99-32a8-8ba9-4b3a5e8a509f/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-february-1-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for QIAGEN NV. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more    
<b>(Read more...)</b>"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : February 1, 2017",2017-02-01 12:36:43 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-february-1-2017/,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : February 1, 2017"
QGEN,QGEN:UW,BBG000GTZC67,Q4 2016 Qiagen NV Earnings Release - 4:00 pm ET,2017-02-01 12:07:03 +0000,http://biz.yahoo.com/research/earncal/20170201.html?t=qgen,Q4 2016 Qiagen NV Earnings Release - 4:00 pm ET
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Hereditary and Rare Disease Solution Chosen by Genomics England,2017-01-30 21:05:00 +0000,http://finance.yahoo.com/news/qiagen-hereditary-rare-disease-solution-210500334.html,"[PR Newswire] - HILDEN, Germany and LONDON, January 30, 2017 /PRNewswire/ -- Bioinformatics content knowledge base will enable interpretation for 100,000 Genomes P roject QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Hereditary and Rare Disease Solution Chosen by Genomics England,2017-01-30 21:05:00 +0000,http://finance.yahoo.com/news/qiagen-hereditary-rare-disease-solution-210500334.html?.tsrc=rss,"HILDEN, Germany and LONDON, January 30, 2017 /PRNewswire/ -- Bioinformatics content knowledge base will enable interpretation for 100,000 Genomes P roject   QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits,2017-01-26 21:05:00 +0000,http://finance.yahoo.com/news/qiagens-quantiferon-tb-test-wins-210500191.html,"[PR Newswire] - HILDEN, Germany and SEOUL, January 26, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON ® -TB Gold (QFT), the modern standard for accuracy ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Announces Adjustment of Conversion Ratio Under its 0.375% Senior Unsecured Convertible Notes due 2019 (ISIN XS1046477235),2017-01-26 07:09:00 +0000,http://finance.yahoo.com/news/qiagen-announces-adjustment-conversion-ratio-070900212.html,"[PR Newswire] - VENLO, Netherlands, January 26, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced the adjustment of the conversion ratio under its 0.375% Senior Unsecured Convertible ..."
QGEN,QGEN:UW,BBG000GTZC67,"Better Buy: Opko Health, Inc. vs. Qiagen",2017-01-20 03:58:38 +0000,http://www.fool.com/investing/2017/01/18/better-buy-opko-health-inc-vs-qiagen.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Opko Health, Inc. vs. Qiagen"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017",2017-01-19 16:16:50 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-value-analysis-nasdaqqgen-january-19-2017/,"QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017"
QGEN,QGEN:UW,BBG000GTZC67,"Better Buy: Opko Health, Inc. vs. Qiagen",2017-01-19 05:36:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wujVIp16Xc4/better-buy-opko-health-inc-vs-qiagen-cm735183,Judging by their stock performances over the past six months Qiagen NASDAQ QGEN has a lot of momentum and Opko Health NASDAQ OPK doesn t But which stock is the better long term pick for investors Here s how Opko Health and Qiagen compare Image source
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase,2017-01-18 21:05:00 +0000,http://finance.yahoo.com/news/qiagen-announces-details-completion-approximately-210500133.html,"[PR Newswire] - VENLO, The Netherlands, January 18, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) (the ""Company"") today announced details for completion of a synthetic share ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : January 18, 2017",2017-01-18 14:52:45 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bearish-manner-qgen-us-january-18-2017/,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : January 18, 2017"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN N.V. to Report Fourth Quarter and Full Year of 2016 Results,2017-01-18 11:19:00 +0000,http://finance.yahoo.com/news/qiagen-n-v-report-fourth-111900581.html,"[PR Newswire] - VENLO, The Netherlands, January 18, 2017 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the fourth quarter and full year ..."
QGEN,QGEN:UW,BBG000GTZC67,Singulex Enters into Collaboration with QIAGEN to Develop Companion Diagnostics,2017-01-10 14:00:00 +0000,http://finance.yahoo.com/news/singulex-enters-collaboration-qiagen-develop-140000797.html,"[PR Newswire] - ALAMEDA, Calif., Jan. 10, 2017 /PRNewswire/ -- Singulex, Inc. today announced that it has entered into a strategic collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) focused on ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite",2017-01-10 13:51:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lWHV3uSWZtY/qiagen-qgen-buys-omicsoft-expands-bioinformatics-suite-cm731478,Global assay technologies major QIAGEN N V QGEN recently announced the acquisition of Cary NC based OmicSoft Corporation The deal will provide QIAGEN access to OmicSoft s powerful multi omics data management infrastructure solutions as well as omics data bank The deal will also
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite",2017-01-10 12:26:12 +0000,http://finance.yahoo.com/news/qiagen-qgen-buys-omicsoft-expands-122612867.html,"QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft,2017-01-09 15:15:00 +0000,http://finance.yahoo.com/news/qiagen-enhances-bioinformatics-portfolio-acquisition-151500475.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, January 9, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of OmicSoft Corporation, providing access ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System,2017-01-09 15:05:00 +0000,http://finance.yahoo.com/news/qiagen-announces-comprehensive-range-enhancements-150500633.html,"[PR Newswire] - GERMANTOWN, Maryland, and HILDEN, Germany, January 9, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a comprehensive range of enhancements for the GeneReader ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Submits QuantiFERON®-TB Gold Plus for U.S. Regulatory Approval,2017-01-09 15:00:00 +0000,http://finance.yahoo.com/news/qiagen-submits-quantiferon-tb-gold-150000166.html,"[PR Newswire] - GERMANTOWN, Maryland and HILDEN, Germany, January 9, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the submission of QuantiFERON ® -TB Gold Plus (QFT ® ..."
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen Poised on Fundamentals, Expansion Plans on Track",2016-12-23 16:00:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QuVC3geGe5Q/qiagen-poised-on-fundamentals-expansion-plans-on-track-cm725635,On Dec 23 2016 we issued an updated research report on Netherlands based molecular diagnostics provider Qiagen NV QGEN The company offers innovative technologies and products for pre analytical sample preparation and molecular diagnostics solutions In the past six months Qiagen
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen Poised on Fundamentals, Expansion Plans on Track",2016-12-23 13:57:01 +0000,http://finance.yahoo.com/news/qiagen-poised-fundamentals-expansion-plans-135701181.html,"Qiagen Poised on Fundamentals, Expansion Plans on Track"
QGEN,QGEN:UW,BBG000GTZC67,Illumina Stock Now Worth a Lot Less? Here's What You Need to Know,2016-12-14 17:58:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uon9mouhH7c/illumina-stock-now-worth-a-lot-less-heres-what-you-need-to-know-cm721445,Wednesday dawned cold and bleak for Illumina NASDAQ ILMN investors as the maker of gene sequencing equipment received its second dose of bad news from Wall Street in a week One week ago Illumina stock got shocked by a price target cut to 100 at Morgan Stanley
QGEN,QGEN:UW,BBG000GTZC67,Illumina Stock Now Worth a Lot Less? Here's What You Need to Know,2016-12-14 16:08:08 +0000,http://www.fool.com/investing/2016/12/14/illumina-stock-now-worth-a-lot-less-heres-what-you.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Illumina Stock Now Worth a Lot Less? Here's What You Need to Know
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Welcomes New Evidence-Based Tuberculosis Testing Guidelines from U.S. Professional Societies,2016-12-12 10:11:00 +0000,http://finance.yahoo.com/news/qiagen-welcomes-evidence-based-tuberculosis-101100840.html,"[PR Newswire] - GERMANTOWN, Maryland, and HILDEN, Germany, December 12, 2016 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today welcomed new evidence-based guidelines for TB screening that have ..."
QGEN,QGEN:UW,BBG000GTZC67,European Stocks Mixed After ECB Extends But Tapers Bond Purchases,2016-12-09 11:16:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eq1a1Ae1ALM/european-stocks-mixed-after-ecb-extends-but-tapers-bond-purchases-cm719094,European equity benchmarks were mixed on Friday as investors digested the European Central Bank s ECB decision to extend its stimulus program by at least nine months an annual drop in the value of goods exported from Germany in October and a meeting among key oil producing nations
QGEN,QGEN:UW,BBG000GTZC67,Qiagen NV (QGEN) Hedge Funds Are Snapping Up,2016-12-07 13:26:53 +0000,http://www.insidermonkey.com/blog/qiagen-nv-qgen-hedge-funds-are-snapping-up-499797/,Qiagen NV (QGEN) Hedge Funds Are Snapping Up
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN launches unique CALR mutation assay for MPN diagnosis,2016-12-01 15:21:16 +0000,http://www.publicnow.com/view/F5B1070C29AA0FF81595610BB3CCAAE64FD7FD33,"[at noodls] - European launch of the new CE marked ipsogen CALR RGQ PCR Kit to improve MPN diagnosis for leukemia patients in line with latest WHO recommendations and clinical guidelines HILDEN, Germany, Dec. 1, 2016 ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and CosmosID launch new plugin for metagenomics analysis,2016-11-23 10:21:11 +0000,http://www.publicnow.com/view/89AC35E6DAD59FD624245225B5D2C5E626451D05,"[at noodls] - Bioinformatics expansion strengthens QIAGEN's Sample to Insight metagenomics solutions Hilden, Germany, and Aarhus, Denmark, November 22, 2016 - QIAGEN and CosmosID, a leading genomic big data company, ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and CosmosID Launch New Plugin for Metagenomics Analysis,2016-11-22 21:03:00 +0000,http://uk.finance.yahoo.com/news/qiagen-cosmosid-launch-plugin-metagenomics-210300549.html,QIAGEN and CosmosID Launch New Plugin for Metagenomics Analysis
QGEN,QGEN:UW,BBG000GTZC67,HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics,2016-11-16 13:38:04 +0000,http://www.publicnow.com/view/B2FCEE1D1873294666DFEE3DDC69E3524D0B5189,"[at noodls] - TUCSON, Ariz., and VENLO, the Netherlands, Nov. 16, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) ('HTG'), a provider of instruments and reagents for molecular profiling applications ..."
QGEN,QGEN:UW,BBG000GTZC67,"ETFs with exposure to QIAGEN NV : November 14, 2016",2016-11-14 19:15:08 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-qiagen-nv-november-14-2016/,"ETFs with exposure to QIAGEN NV : November 14, 2016"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016",2016-11-10 14:29:57 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-qgen-us-earnings-analysis-q3-2016-by-the-numbers-november-10-2016/,"QIAGEN NV :QGEN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN GeneReader NGS System to relaunch in U.S. market,2016-11-09 07:09:13 +0000,http://www.publicnow.com/view/4905694791E0169058713FB1707247642A1CF53A,"[at noodls] - New improved chemistry for first Sample to Insight next-generation sequencing solution to be made available to first customers in December 2016 Charlotte, North Carolina, and Hilden, Germany, November ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's GeneReader NGS System Streamlines Data Management for Labs,2016-11-09 07:05:00 +0000,http://finance.yahoo.com/news/qiagens-genereader-ngs-system-streamlines-070500045.html,"[PR Newswire] - HILDEN, Germany and CHARLOTTE, North Carolina, November 9, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with lab informatics company Genohm ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN GeneReader NGS System to Relaunch in U.S. Market,2016-11-09 07:05:00 +0000,http://finance.yahoo.com/news/qiagen-genereader-ngs-system-relaunch-070500705.html,"[PR Newswire] - Frankfurt Prime Standard: QIA) today announced the validation of new and improved sequencing chemistry for its GeneReader NGS System, the world's first complete Sample to Insight solution making the benefits of next-generation sequencing (NGS) accessible to any laboratory. QIAGEN published new, excellent performance data of the QIAGEN GeneReader NGS System using the new sequencing chemistry and QIAGEN's GeneRead QIAact Actionable Insights Tumor Panel. Data generated from the GeneReader NGS System with the new chemistry showed 100% concordance with results of QIAGEN's FDA approved therascreen KRAS RGQ PCR assay, the company's CE-labelled therascreen RAS Extension Pyro Assay as well as with an alternative next-generation sequencing (NGS) sequencer from another vendor."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : November 7, 2016",2016-11-07 12:17:17 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-november-7-2016/,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : November 7, 2016"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen NV Jumps After Beating Its Earnings Guidance,2016-11-03 22:08:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N4Cd6jS0Zmo/qiagen-nv-jumps-after-beating-its-earnings-guidance-cm703687,Image source Getty Images Qiagen NASDAQ QGEN is up 10 5 at 3 26 p m EDT after releasing solid third quarter earnings with adjusted earnings per share beating management s guidance by 0 01 Qiagen results The raw numbers
QGEN,QGEN:UW,BBG000GTZC67,Qiagen NV Jumps After Beating Its Earnings Guidance,2016-11-03 20:12:49 +0000,http://www.fool.com/investing/2016/11/03/qiagen-nv-jumps-after-beating-its-earnings-guidanc.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Qiagen NV Jumps After Beating Its Earnings Guidance
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen (QGEN) Tops Q3 Earnings & Sales, Provides '17 View",2016-11-03 16:10:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/poRouXVArcI/qiagen-qgen-tops-q3-earnings-sales-provides-17-view-cm703338,Qiagen NV QGEN reported third quarter 2016 adjusted earnings per share EPS of 29 cents beating both the Zacks Consensus Estimate and the year ago adjusted number by 7 7 At constant exchange rate or CER too the company reported adjusted EPS of 29 cents Adjusted EPS at CER exceeded
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen (QGEN) Tops Q3 Earnings & Sales, Provides '17 View",2016-11-03 14:07:02 +0000,http://finance.yahoo.com/news/qiagen-qgen-tops-q3-earnings-140702728.html,"Qiagen (QGEN) Tops Q3 Earnings & Sales, Provides '17 View"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen upgraded by BofA/Merrill,2016-11-03 11:33:15 +0000,http://finance.yahoo.com/q/ud?s=QGEN,Qiagen upgraded by BofA/Merrill
QGEN,QGEN:UW,BBG000GTZC67,Edited Transcript of QGEN earnings conference call or presentation 2-Nov-16 9:00pm GMT,2016-11-03 01:43:07 +0000,http://finance.yahoo.com/news/edited-transcript-qgen-earnings-conference-014307355.html,Edited Transcript of QGEN earnings conference call or presentation 2-Nov-16 9:00pm GMT
QGEN,QGEN:UW,BBG000GTZC67,Qiagen beats Street 3Q forecasts,2016-11-02 21:21:41 +0000,http://sg.finance.yahoo.com/news/qiagen-beats-street-3q-forecasts-212141526.html,Qiagen beats Street 3Q forecasts
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN launches restructuring initiatives, revises outlook for 2016 earnings and provides initial net sales and adjusted earnings guidance for 2017",2016-11-02 20:22:00 +0000,http://www.publicnow.com/view/798678C4810444A29D9EC32E7AD9F2E123EFEEDD,"[at noodls] - Venlo, The Netherlands, November 2, 2016 - QIAGEN N.V. announces a series of restructuring initiatives to improve efficiency and profitability through targeted actions planned to be implemented in the ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN reports results for third quarter and first nine months of 2016,2016-11-02 20:21:50 +0000,http://www.publicnow.com/view/11526483BCFB35EE32A68B94FA22125F6A618BDB,"[at noodls] - QIAGEN records strong third quarter with accelerating 2016 performance: Q3 2016: Net sales of $338.7 million (+8% actual, +9% constant exchange rates, CER); EPS of $0.14; adjusted EPS of $0.29 ($0.29 CER) ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reports Results for Third Quarter and First Nine Months of 2016,2016-11-02 20:03:00 +0000,http://finance.yahoo.com/news/qiagen-reports-results-third-quarter-200300919.html,"[PR Newswire] - VENLO, the Netherlands, November 2, 2016 /PRNewswire/ -- QIAGEN records strong third quarter with accelerating 2016 performance : Q3 2016: Net sales of $338.7 million (+8% actual, +9% constant exchange ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN To Record Restructuring Charge Of About $0.22-0.23 Per Share In Q4,2016-11-02 17:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5qCRVRfhtOY/qiagen-to-record-restructuring-charge-of-about-022023-per-share-in-q4-20161102-01083,QIAGEN To Record Restructuring Charge Of About $0.22-0.23 Per Share In Q4
QGEN,QGEN:UW,BBG000GTZC67,Q3 2016 Qiagen NV Earnings Release - 4:00 pm ET,2016-11-02 11:07:01 +0000,http://biz.yahoo.com/research/earncal/20161102.html?t=qgen,Q3 2016 Qiagen NV Earnings Release - 4:00 pm ET
QGEN,QGEN:UW,BBG000GTZC67,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More",2016-11-01 13:15:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rxmVtmQScKM/drug-stocks-to-watch-for-earnings-on-nov-2-agn-zts-more-cm701594,The Q3 earnings season moves into the second half of the reporting cycle with results from 291 S amp P 500 members as of Oct 28 accounting for 58 2 of the index s total market capitalization according to the Earnings Preview report While total earnings for these 291 index members were
QGEN,QGEN:UW,BBG000GTZC67,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More",2016-11-01 12:20:12 +0000,http://finance.yahoo.com/news/drug-stocks-watch-earnings-nov-122012908.html,"Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More"
QGEN,QGEN:UW,BBG000GTZC67,5 Healthcare Stocks Poised to Trump Q3 Earnings,2016-10-31 22:15:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iisq-O1OdeA/5-healthcare-stocks-poised-to-trump-q3-earnings-cm701421,The past few months have been pretty rough for the healthcare sector with the drug pricing issue taking the center stage once again This time it was the massive price hike of Mylan N V s MYL severe allergy treatment EpiPen that sparked controversies With no possibility of dying down
QGEN,QGEN:UW,BBG000GTZC67,5 Healthcare Stocks Poised to Trump Q3 Earnings,2016-10-31 19:55:07 +0000,http://finance.yahoo.com/news/5-healthcare-stocks-poised-trump-195507008.html,5 Healthcare Stocks Poised to Trump Q3 Earnings
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN shareholders approve return of approximately $250 million in cash to shareholders via synthetic share repurchase,2016-10-26 09:55:08 +0000,http://www.publicnow.com/view/62CBDA975FD437CAB5E7B44269E8B69F18374AB6,"[at noodls] - Adjustment to capital structure through reduction in number of shares outstanding and direct capital repayment to shareholders expected to be completed in January 2017 Venlo, the Netherlands, October 26, ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Shareholders Approve Return of Approximately $250 million in Cash to Shareholders via Synthetic Share Repurchase,2016-10-26 09:54:00 +0000,http://finance.yahoo.com/news/qiagen-shareholders-approve-return-approximately-095400853.html,"[PR Newswire] - VENLO, the Netherlands, October 26, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that shareholders overwhelmingly approved a proposal to return approximately ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Shareholders Approve $250 Mln Synthetic Share Repurchase,2016-10-26 06:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aTYIdyZ7hsg/qiagen-shareholders-approve-250-mln-synthetic-share-repurchase-20161026-00108,QIAGEN Shareholders Approve $250 Mln Synthetic Share Repurchase
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN launches QIAscout for single-cell isolation,2016-10-20 20:09:06 +0000,http://www.publicnow.com/view/92230AA2955639C6802803E1241190E96AA45BE5,"[at noodls] - Compact, versatile and yet very affordable instrument provides unique front-end in workflows for molecular analysis of individual cells Hilden, Germany, and Germantown, Maryland, October 20, 2016- QIAGEN ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches QIAscout for Single-cell Isolation,2016-10-20 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-launches-qiascout-single-cell-200500321.html,"[PR Newswire] - HILDEN, Germany, and GERMANTOWN, Maryland, October 20, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced launch of QIAscout, a novel instrument for isolation ..."
QGEN,QGEN:UW,BBG000GTZC67,"ETF’s with exposure to QIAGEN NV : October 19, 2016",2016-10-19 17:36:00 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-qiagen-nv-october-19-2016/,"ETF’s with exposure to QIAGEN NV : October 19, 2016"
QGEN,QGEN:UW,BBG000GTZC67,"What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers",2016-10-19 16:56:00 +0000,https://www.thestreet.com/story/13858017/1/what-ibm-s-genomic-partnership-with-quest-says-about-thermo-fisher-diagnostics-peers.html?puc=yahoo&cm_ven=YAHOO,"What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN unveils unique Sample to Insight solutions for liquid biopsies and hereditary diseases,2016-10-17 20:13:04 +0000,http://www.publicnow.com/view/5E948D1DA03493D793D98FA09A00C25FC613BE86,"[at noodls] - All-in-One library prep kit, plus collection, stabilization and bioinformatics solutions enable NIPT and cancer research Vancouver, Canada, and Hilden, Germany, October 17, 2016- QIAGEN N.V. (NASDAQ: QGEN; ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Unveils Unique Sample to Insight Solutions for Liquid Biopsies and Hereditary Diseases,2016-10-17 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-unveils-unique-sample-insight-200500625.html,"[PR Newswire] - VANCOUVER and HILDEN, Germany, October 17, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq ® cfDNA All-in-One Kit, combining cell-free ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's High-Throughput Solutions for Human ID Database,2016-10-13 15:43:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AHPHhFVpF6Y/qiagens-high-throughput-solutions-for-human-id-database-cm692811,QIAGEN N V QGEN in collaboration with Hamilton Robotics has launched automated high throughput solutions for human identity ID databases These solutions target the growing need for DNA fingerprinting of samples in human ID databases Its automated workflows allow high throughput
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN's High-Throughput Solutions for Human ID Database,2016-10-13 13:39:01 +0000,http://finance.yahoo.com/news/qiagens-high-throughput-solutions-human-133901300.html,QIAGEN's High-Throughput Solutions for Human ID Database
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : October 12, 2016",2016-10-12 12:49:11 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bearish-manner-qgen-us-october-12-2016/,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : October 12, 2016"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches QIAsymphony SP Device Outside the U.S.,2016-10-11 16:21:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcC4Y3vGpGs/qiagen-launches-qiasymphony-sp-device-outside-the-us-cm691889,Molecular diagnostics major QIAGEN N V QGEN recently announced the launch of QIAsymphony SP instrument as a front end option for sample processing for its GeneReader NGS System outside the U S The GeneReader NGS workflow can now integrate with the system allowing laboratories to
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches QIAsymphony SP Device Outside the U.S.,2016-10-11 14:02:02 +0000,http://finance.yahoo.com/news/qiagen-launches-qiasymphony-sp-device-140202018.html,QIAGEN Launches QIAsymphony SP Device Outside the U.S.
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN N.V. to Report Third Quarter and First Nine Months of 2016 Results,2016-10-11 08:42:00 +0000,http://finance.yahoo.com/news/qiagen-n-v-report-third-084200881.html,"[PR Newswire] - VENLO, the Netherlands, October 11, 2016 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the third quarter and first nine ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN launches high-throughput solutions for human ID databases,2016-10-10 20:13:05 +0000,http://www.publicnow.com/view/0C2B9B695CBB87EF90519C6FA6A56346D6EAC231,"[at noodls] - Partnering with Hamilton Robotics to deliver automated workflows for DNA fingerprinting Hilden, Germany, and Germantown, Maryland, October 10, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Launches High-throughput Solutions for Human ID Databases,2016-10-10 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-launches-high-throughput-solutions-200500560.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, October 10, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of automated high-throughput solutions, developed ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Introduces QIAsymphony Sample Processing Option to GeneReader NGS Workflow for Non U.S. Customers,2016-10-05 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-introduces-qiasymphony-sample-processing-200500928.html,"[PR Newswire] - HILDEN, Germany, October 5, 2016 /PRNewswire/ -- QIAsymphony SP front - end adds higher sample throughput and additional flexibility to GeneReader NGS System QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and ICMP to develop first NGS workflow for identification of missing persons,2016-09-29 20:10:04 +0000,http://www.publicnow.com/view/18E32E9FC341023C1F9BABC8F1D0594E3ABAF6EF,"[at noodls] - Collaboration targets 'Sample to Insight' sequencing solutions to enhance research and applications in human identification Hilden, Germany, and The Hague, The Netherlands, September 29, 2016- QIAGEN N.V. ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN and ICMP to Develop First NGS Workflow for Identification of Missing Persons,2016-09-29 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-icmp-develop-first-ngs-200500883.html,"[PR Newswire] - HILDEN, Germany and THE HAGUE, The Netherlands, September 29, 2016 /PRNewswire/ -- Collaboration target s "" Sample to Insight "" sequencing solutions to enhance research and applications in human ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen: Molecular Diagnostics & Expansion Plans on Track,2016-09-16 15:21:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UGp09Hd2_zQ/qiagen-molecular-diagnostics-expansion-plans-on-track-cm680509,On Sep 13 2016 we issued an updated research report on Netherlands based molecular diagnostics provider Qiagen NV QGEN The company offers innovative technologies and products for pre analytical sample preparation and molecular diagnostics solutions The company s promising second
QGEN,QGEN:UW,BBG000GTZC67,Qiagen: Molecular Diagnostics & Expansion Plans on Track,2016-09-16 13:14:01 +0000,http://finance.yahoo.com/news/qiagen-molecular-diagnostics-expansion-plans-131401199.html,Qiagen: Molecular Diagnostics & Expansion Plans on Track
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Reaches Analyst Target Price,2016-09-15 14:14:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mY89pU3feEc/qiagen-reaches-analyst-target-price-cm679838,In recent trading shares of Qiagen N V Symbol QGEN have crossed above the average analyst 12 month target price of 25 81 changing hands for 25 99 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation or re
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN comments on preliminary injunction and confirms intention to defend its U.S. intellectual property position,2016-09-10 15:42:08 +0000,http://www.publicnow.com/view/299160026A2D4E2E7C5BBB1D4C3619FFB5FB4814,[at noodls] - QIAGEN comments on preliminary injunction and confirms intention to defend its U.S. intellectual property position The text version of this document is not available at the moment. The original content ...
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Comments on Preliminary Injunction and Confirms Intention to Defend its U.S. Intellectual Property Position,2016-09-10 15:30:00 +0000,http://finance.yahoo.com/news/qiagen-comments-preliminary-injunction-confirms-153000639.html,"[PR Newswire] - VENLO, The Netherlands and HILDEN, Germany, September 10, 2016 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) commented on a decision issued late on Friday, September 9, by the U.S. ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN welcomes U.S. guidance for latent TB testing in primary care,2016-09-08 16:49:06 +0000,http://www.publicnow.com/view/FDF821C3CD9E94066C6DF998D1E10BE71F83FC29,"[at noodls] - U.S. Preventive Services Task Force issues recommendations to screen high-risk patients Germantown, Maryland, and Hilden, Germany, September 8, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Welcomes U.S. Guidance for Latent TB Testing in Primary Care,2016-09-08 16:46:00 +0000,http://finance.yahoo.com/news/qiagen-welcomes-u-guidance-latent-164600862.html,"[PR Newswire] - GERMANTOWN, Maryland, and HILDEN, Germany, September 8, 2016 /PRNewswire/ -- U.S. Preventive Services Task Force issues recommendations to screen high-risk patients QIAGEN N.V. (NASDAQ: QGEN; Frankfurt ..."
QGEN,QGEN:UW,BBG000GTZC67,Danaher Corporation (DHR) Buys Cepheid (CPHD): Who’s Next?,2016-09-06 20:18:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0JixjToEpDo/danaher-corporation-dhr-buys-cepheid-cphd-whos-next-cm675191,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Danaher Corporation 160 NYSE DHR announced today 160 that it 160 is buying genetic testing company Cepheid 160 NASDAQ CPHD 160 in a deal
QGEN,QGEN:UW,BBG000GTZC67,"European Stocks Fall Before Yellen Speech Led by Mining Stocks, Drugmakers",2016-08-25 10:01:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IMuBq-Nzy-A/european-stocks-fall-before-yellen-speech-led-by-mining-stocks-drugmakers-cm669911,European stocks were lower on Thursday morning as investors looked ahead to a speech due to be delivered by Federal Reserve Chair Janet Yellen on Friday which may provide clues on the direction of US monetary policy in coming
QGEN,QGEN:UW,BBG000GTZC67,BUZZ-European pharma: top fallers on Stoxx 600 amid pricing pressure concern,2016-08-25 08:58:22 +0000,http://uk.finance.yahoo.com/news/buzz-european-pharma-top-fallers-085822693.html,BUZZ-European pharma: top fallers on Stoxx 600 amid pricing pressure concern
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN announces plans to return approximately $250 million to shareholders via synthetic share repurchase proposal,2016-08-16 09:51:01 +0000,http://www.publicnow.com/view/3F8F2E86FF3AF7268450D05279035C29F9E2D613,"[at noodls] - Proposal would adjust capital structure through 4% reduction in number of shares outstanding and direct capital repayment to shareholders Venlo, the Netherlands, August 14, 2016- QIAGEN N.V. (NASDAQ: QGEN; ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Announces Plans to Return Approximately $250 Million to Shareholders Via Synthetic Share Repurchase Proposal,2016-08-14 12:48:00 +0000,http://finance.yahoo.com/news/qiagen-announces-plans-return-approximately-124800373.html,"[PR Newswire] - VENLO, Netherlands, August 14, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to return approximately $250 million to shareholders through a synthetic ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Says Plans To Return $250 Mln To Shareholders Via Repurchase Proposal,2016-08-14 09:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/58M7zTrgM6A/qiagen-says-plans-to-return-250-mln-to-shareholders-via-repurchase-proposal-20160814-00008,QIAGEN Says Plans To Return $250 Mln To Shareholders Via Repurchase Proposal
QGEN,QGEN:UW,BBG000GTZC67,"1,750 Reasons to Like Qiagen NV",2016-08-04 11:56:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qkvCpsrntJM/1750-reasons-to-like-qiagen-nv-cm659937,"QIAsymphony is on track for total placements to reach 1,750 by the end of the year. Image source  Qiagen.  Qiagen NV 's(NASDAQ  QGEN) second quarter numbers weren't particularly great, especially on the"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen (QGEN) Tops Q2 Earnings & Sales; Margins Drop Y/Y,2016-08-01 15:57:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yx3VKlFNoEU/qiagen-qgen-tops-q2-earnings-sales-margins-drop-yy-cm658017,"Qiagen NVQGEN reported second quarter 2016 adjusted earnings of 24 cents per share, beating the Zacks Consensus Estimate by a penny. On a year over year basis, however, adjusted earnings declined 7.7%. At constant exchange rate or CER also,"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen (QGEN) Tops Q2 Earnings & Sales; Margins Drop Y/Y,2016-08-01 14:08:02 +0000,http://finance.yahoo.com/news/qiagen-qgen-tops-q2-earnings-140802056.html,Qiagen (QGEN) Tops Q2 Earnings & Sales; Margins Drop Y/Y
QGEN,QGEN:UW,BBG000GTZC67,"Why Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks",2016-07-30 10:23:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ed_XwSOLG2Q/why-carbo-ceramics-inc-crr-hewlett-packard-enterprise-co-hpe-and-qiagen-nv-qgen-are-3-of-todays-best-stocks-cm657697,Stocks closed mostly higher Friday despite a disappointing second quarter GDP report. Data from the U.S. Commerce Department show the U.S. economy grew 1.2% in
QGEN,QGEN:UW,BBG000GTZC67,Edited Transcript of QGEN earnings conference call or presentation 29-Jul-16 1:30pm GMT,2016-07-29 19:36:33 +0000,http://finance.yahoo.com/news/edited-transcript-qgen-earnings-conference-193633533.html,Edited Transcript of QGEN earnings conference call or presentation 29-Jul-16 1:30pm GMT
QGEN,QGEN:UW,BBG000GTZC67,Why Qiagen NV Jumped Higher Today,2016-07-29 18:28:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lMRbC8id_3Y/why-qiagen-nv-jumped-higher-today-cm657483,QIAsymphony automation platform. Image source  Qiagen.  What  Qiagen (NASDAQ  QGEN) is up 13% at noon EDT today after the company reported solid second quarter earnings and a commitment to return $300
QGEN,QGEN:UW,BBG000GTZC67,Stocks Close Nearly Flat Following Another Lackluster Session - U.S. Commentary,2016-07-29 16:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d1vPGzRrV8U/stocks-close-nearly-flat-following-another-lackluster-session--us-commentary-20160729-00892,Stocks Close Nearly Flat Following Another Lackluster Session - U.S. Commentary
QGEN,QGEN:UW,BBG000GTZC67,Qiagen (QGEN) Stock Soars as Q2 Results Surpass Expectations,2016-07-29 15:26:00 +0000,https://www.thestreet.com/story/13657971/1/qiagen-qgen-stock-soars-as-q2-results-surpass-expectations.html?puc=yahoo&cm_ven=YAHOO,Qiagen (QGEN) Stock Soars as Q2 Results Surpass Expectations
QGEN,QGEN:UW,BBG000GTZC67,Stocks Fluctuate But S&P 500 Still Reaches New Record High - U.S. Commentary,2016-07-29 12:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kNGbY1Tq1RM/stocks-fluctuate-but-sp-500-still-reaches-new-record-high--us-commentary-20160729-00690,Stocks Fluctuate But S&P 500 Still Reaches New Record High - U.S. Commentary
QGEN,QGEN:UW,BBG000GTZC67,Stocks Fluctuate But S&P 500 Still Reaches New Record High - U.S. Commentary,2016-07-29 12:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jqQNu43uSmQ/stocks-fluctuate-but-sp-500-still-reaches-new-record-high--us-commentary-20160729-00689,Stocks Fluctuate But S&P 500 Still Reaches New Record High - U.S. Commentary
QGEN,QGEN:UW,BBG000GTZC67,DAX Holds Steady As Banks Rally,2016-07-29 06:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ir3PObHCpaw/dax-holds-steady-as-banks-rally-20160729-00165,DAX Holds Steady As Banks Rally
QGEN,QGEN:UW,BBG000GTZC67,Qiagen beats Street 2Q forecasts,2016-07-28 21:28:09 +0000,http://sg.finance.yahoo.com/news/qiagen-beats-street-2q-forecasts-212809325.html,Qiagen beats Street 2Q forecasts
QGEN,QGEN:UW,BBG000GTZC67,Ad hoc Announcement of Insider Information according to Article 17 MAR,2016-07-28 20:18:20 +0000,http://www.publicnow.com/view/5D2A8F58F52BF6128A055F8E0954EB5005282FD0,"[at noodls] - QIAGEN intends to return capital of US$300 million to shareholders by end of 2017 Venlo, The Netherlands, July 28, 2016 - QIAGEN N.V. announces that it intends to return capital to its shareholders in ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN reports results for second quarter of 2016; increased commitment to return $300 million of capital to shareholders by end-2017,2016-07-28 20:18:17 +0000,http://www.publicnow.com/view/B9DD78792D6BDD84FFFFC4144092523D62376115,"[at noodls] - Q2 2016 results show QIAGEN delivering on goals for acceleration during the year Net sales of $334.4 million (+5% actual, +6% constant exchange rates, CER); EPS of $0.09; adjusted EPS of $0.24 ($0.24 CER) ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017,2016-07-28 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-reports-results-second-quarter-200500961.html,"[PR Newswire] - VENLO, The Netherlands, July 28, 2016 /PRNewswire/ -- Q2 2016 results show QIAGEN delivering on goals for acceleration during the year Net sales of $334.4 million (+5% actual, +6% constant exchange ..."
QGEN,QGEN:UW,BBG000GTZC67,QGEN Makes Bullish Cross Above Critical Moving Average,2016-07-28 17:26:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6TA4C-fnqvA/qgen-makes-bullish-cross-above-critical-moving-average-cm656608,"In trading on Thursday, shares of Qiagen N.V. (Symbol QGEN) crossed above their 200 day moving average of $23.29, changing hands as high as $23.31 per share. Qiagen N.V. shares are currently trading up about 0.5% on the day."
QGEN,QGEN:UW,BBG000GTZC67,Q2 2016 Qiagen NV Earnings Release - 4:00 pm ET,2016-07-28 11:07:01 +0000,http://biz.yahoo.com/research/earncal/20160728.html?t=qgen,Q2 2016 Qiagen NV Earnings Release - 4:00 pm ET
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN launches “Digital NGS” solutions with unique Molecular Index Technology to reliably detect all genetic variation,2016-07-27 20:18:10 +0000,http://www.publicnow.com/view/E351B2330758E7560115675235DC37562FB09142,"[at noodls] - QIAseq Targeted NGS panels deliver highly sensitive, unbiased and accurate NGS insights Hilden, Germany, and Germantown, Maryland, July 27, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN launches novel integrated system for collection, stabilization, transport, storage and isolation of circulating cell-free DNA",2016-07-27 20:18:10 +0000,http://www.publicnow.com/view/8669CAC1534DBA0C26DBBE0BA318E7346514821E,"[at noodls] - PAXgene Blood ccfDNA enhances handling and workflow convenience for liquid biopsy applications in prenatal testing and cancer research Hilden, Germany, and Germantown, Maryland, July 27, 2016- QIAGEN N.V. ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Launches ""Digital NGS"" Solutions with Unique Molecular Index Technology to Reliably Detect All Genetic Variation",2016-07-27 20:07:00 +0000,http://finance.yahoo.com/news/qiagen-launches-digital-ngs-solutions-200700055.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, July 27, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of a comprehensive portfolio of novel QIAseq ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN Launches Novel Integrated System for Collection, Stabilization, Transport, Storage and Isolation of Circulating Cell-free DNA",2016-07-27 20:05:00 +0000,http://finance.yahoo.com/news/qiagen-launches-novel-integrated-system-200500254.html,"[PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, July 27, 2016 /PRNewswire/ -- P AXg ene Blood ccfDNA enhances handling and workflow convenience f o r liquid biopsy applications in prenatal testing and cancer ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen sees call buying before earnings,2016-07-18 19:07:20 +0000,http://finance.yahoo.com/news/qiagen-sees-call-buying-earnings-190720540.html,Qiagen sees call buying before earnings
QGEN,QGEN:UW,BBG000GTZC67,September 16th Options Now Available For Qiagen (QGEN),2016-07-18 17:14:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gtrIt_EeMzs/september-16th-options-now-available-for-qiagen-qgen-cm650702,"Investors in Qiagen N.V. (Symbol QGEN) saw new options become available today, for the September 16th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the QGEN options chain for the new September 16th"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN N.V. to Report Second Quarter and First Half of 2016 Results,2016-07-14 09:14:00 +0000,http://finance.yahoo.com/news/qiagen-n-v-report-second-091400119.html,"[PR Newswire] - VENLO, Netherlands, July 14, 2016 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of 2016 ..."
QGEN,QGEN:UW,BBG000GTZC67,Test Aids Prostate Cancer Treatment,2016-07-07 01:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3J9ioVQg8uc/test-aids-prostate-cancer-treatment-20160707-00013,Test Aids Prostate Cancer Treatment
QGEN,QGEN:UW,BBG000GTZC67,"ETF’s with exposure to QIAGEN NV : July 6, 2016",2016-07-06 18:37:41 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-qiagen-nv-july-6-2016/,"ETF’s with exposure to QIAGEN NV : July 6, 2016"
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 6, 2016",2016-07-06 12:21:38 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bearish-manner-qgen-us-july-6-2016/,"QIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 6, 2016"
QGEN,QGEN:UW,BBG000GTZC67,Exiqon A/S - CALL FOR REDEMPTION OF MINORITY SHAREHOLDERS IN EXIQON A/S UNDER SECTIONS 70 AND 72 OF THE DANISH COMPANIES ACT,2016-07-06 07:31:09 +0000,http://www.publicnow.com/view/C0F459C5EEEB48BCBAE51231B4C262309493EC1B,"[at noodls] - Exiqon A/S Company Announcement CALL FOR REDEMPTION OF MINORITY SHAREHOLDERS IN EXIQON A/S UNDER SECTIONS 70 AND 72 OF THE DANISH COMPANIES ACT Copenhagen, 2016-07-06 09:17 CEST (GLOBE NEWSWIRE) -- As ..."
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV :QGEN-US: Earnings Analysis: For the six months ended December 31, 2015 : July 5, 2016",2016-07-05 14:05:39 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-qgen-us-earnings-analysis-for-the-six-months-ended-december-31-2015-july-5-2016/,"QIAGEN NV :QGEN-US: Earnings Analysis: For the six months ended December 31, 2015 : July 5, 2016"
QGEN,QGEN:UW,BBG000GTZC67,"Better Buy: Opko Health, Inc. vs. Qiagen",2016-07-02 19:45:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BU9OkByjs68/better-buy-opko-health-inc-vs-qiagen-cm644240,"Image source  Getty Images.  Shares of both Qiagen (NASDAQ  QGEN) and Opko Health, Inc. (NASDAQ  OPK) are trading at relative discounts to prices seen not long ago, and investors are wondering"
QGEN,QGEN:UW,BBG000GTZC67,"Better Buy: Opko Health, Inc. vs. Qiagen",2016-07-02 18:05:00 +0000,http://www.fool.com/investing/2016/07/02/better-buy-opko-health-inc-vs-qiagen.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Opko Health, Inc. vs. Qiagen"
QGEN,QGEN:UW,BBG000GTZC67,The Implied Analyst 12-Month Target For IWR,2016-06-28 14:48:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nC956Jjhkrw/the-implied-analyst-12-month-target-for-iwr-cm642061,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
QGEN,QGEN:UW,BBG000GTZC67,Buy These 5 Stocks This Week for Breakout Gains,2016-06-28 12:34:00 +0000,https://www.thestreet.com/story/13621873/1/buy-these-5-stocks-this-week-for-breakout-gains.html?puc=yahoo&cm_ven=YAHOO,Buy These 5 Stocks This Week for Breakout Gains
QGEN,QGEN:UW,BBG000GTZC67,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : June 24, 2016",2016-06-24 12:33:07 +0000,http://www.capitalcube.com/blog/index.php/qiagen-nv-breached-its-50-day-moving-average-in-a-bullish-manner-qgen-us-june-24-2016/,"QIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : June 24, 2016"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN announces successful completion of tender offer for shares in Exiqon,2016-06-23 09:59:07 +0000,http://www.publicnow.com/view/EEDADFC62979318A121A57F8C1EC5B08350FBFEA,"[at noodls] - Transaction will enhance leadership position in RNA solutions from Sample to Insight Venlo, The Netherlands, June 23, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Announces Successful Completion of Tender Offer for Shares in Exiqon,2016-06-23 09:45:00 +0000,http://finance.yahoo.com/news/qiagen-announces-successful-completion-tender-094500011.html,"[PR Newswire] - VENLO, The Netherlands, June 23, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the successful completion of the conditional, voluntary public tender offer ..."
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen's Q1 Results Hit by Currency, Competition Rife",2016-06-21 15:22:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JqIyY6PwrC0/qiagens-q1-results-hit-by-currency-competition-rife-cm638331,"On Jun 21, we issued an updated research report on Venlo, Netherlands based Qiagen N.V.QGEN a global provider of innovative technologies and products for pre analytical sample preparation and molecular diagnostics solutions. The company currently carries a Zacks Rank"
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen's Q1 Results Hit by Currency, Competition Rife",2016-06-21 13:32:01 +0000,http://finance.yahoo.com/news/qiagens-q1-results-hit-currency-133201490.html,"Qiagen's Q1 Results Hit by Currency, Competition Rife"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Joins Consortium to Map Microbial Genomes in 54 Cities,2016-06-21 11:49:00 +0000,http://finance.yahoo.com/news/qiagen-joins-consortium-map-microbial-114900056.html,"[PR Newswire] - NEW YORK and HILDEN, Germany, June 21, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with Weill Cornell Medicine in a global study seeking ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN joins consortium to map microbial genomes in 54 cities,2016-06-21 11:29:03 +0000,http://www.publicnow.com/view/E6F0B072D350755F17A7F3D8987B85D36517768F,"[at noodls] - Project that measured pathogens in New York City subways goes global this summer New York, N.Y., and Hilden, Germany, June 21, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced ..."
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen Sets 2016 Goals, Plans To Invest To Accelerate Growth Drivers",2016-06-21 05:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lkaq2uuBGBQ/qiagen-sets-2016-goals-plans-to-invest-to-accelerate-growth-drivers-20160621-00116,"Qiagen Sets 2016 Goals, Plans To Invest To Accelerate Growth Drivers"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen Enters Oversold Territory (QGEN),2016-06-16 18:06:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OUn1Z9nDlfo/qiagen-enters-oversold-territory-qgen-cm636536,"Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen???s QIAsure Test to Determine Cervical Cancer Risks,2016-06-15 14:07:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rmEEDL3Dwws/qiagens-qiasure-test-to-determine-cervical-cancer-risks-cm635788,"Qiagen N VQGEN recently started simultaneous launch of its QIAsure Methylation molecular diagnostic test in Europe, Middle East and Africa. Notably, this CE IVD marked assay helps in determining individual patient's risk of developing cervical cancer. Interestingly, the launch"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen???s QIAsure Test to Determine Cervical Cancer Risks,2016-06-15 12:33:12 +0000,http://finance.yahoo.com/news/qiagen-qiasure-test-determine-cervical-123312407.html,Qiagen???s QIAsure Test to Determine Cervical Cancer Risks
QGEN,QGEN:UW,BBG000GTZC67,MDxHealth (R): Grants QIAGEN Rights to MSP Technology for QIAsure Methylation Test for Cervical Cancer Risk,2016-06-15 05:29:11 +0000,http://www.publicnow.com/view/36F7EF076872CCCD8EB6787591D0995E1E5779F5,"[at noodls] - IRVINE, CA, and HERSTAL, BELGIUM - June 15, 2016 - MDxHealth SA (Euronext: MDXH.BR), announced today that it has granted a non-exclusive worldwide license for its patented methylation-specific PCR (MSP) ..."
QGEN,QGEN:UW,BBG000GTZC67,MDxHealth Grants QIAGEN Rights To MSP Technology For Cervical Cancer Test,2016-06-15 01:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8TgiDXZVUkE/mdxhealth-grants-qiagen-rights-to-msp-technology-for-cervical-cancer-test-20160615-00020,MDxHealth Grants QIAGEN Rights To MSP Technology For Cervical Cancer Test
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN launches QIAsure Methylation Test to determine cervical cancer risk,2016-06-14 20:19:01 +0000,http://www.publicnow.com/view/5D375A2D4598E754349483BF6B4AEEDC75D7DC53,"[at noodls] - New follow-up assayhelps stratify patients with transforming HPV infections Hilden, Germany, and Salzburg, Austria, June 14, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN changes offer conditions for acquisition of shares in Exiqon A/S,2016-06-08 14:08:04 +0000,http://www.publicnow.com/view/5365DB59D5B0A133915E40EC8298F36CDD730110,"[at noodls] - Acceptance rate lowered to 89.20% of share capital and voting rights to reflect possible effect of warrants Venlo, The Netherlands, June 8, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN announces second offer extension for the acquisition of shares in Exiqon A/S,2016-06-03 13:35:07 +0000,http://www.publicnow.com/view/F3C861E1BAC59C6EF5F0C0A15B721A8BEE27E14B,"[at noodls] - Offer for DKK 18 per share remains valid until 20 June 2016 Venlo, The Netherlands, June 3, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced another extension of the Offer ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN forms Lung Cancer Expert Alliance,2016-06-02 20:15:05 +0000,http://www.publicnow.com/view/CF6B3A1D24E0C2FC9C0684C1BDDC32B1CC545B6F,"[at noodls] - Key opinion leaders' expertise to guide design of new gene panels for GeneReader NGS Hilden, Germany, and Germantown, Maryland, June 2, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN launches liquid biopsy workflow for GeneReader NGS System,2016-06-01 20:25:10 +0000,http://www.publicnow.com/view/8580CE83DCB70F8675F4E4403ED53CA4A073428C,"[at noodls] - Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples Hilden, Germany, and Germantown, Maryland, June 1, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: ..."
QGEN,QGEN:UW,BBG000GTZC67,Horizon Discovery Group’s Molecular Reference Standards integrated into QIAGEN GeneReader NGS System,2016-06-01 08:43:10 +0000,http://www.publicnow.com/view/E627C5299AB9AA4AC679706B0584186C896BB3EA,[at noodls] - Deal demonstrates the impact Horizon's Reference Standards are having in supporting the rapidly growing Next Generation Sequencing (NGS) market Future joint collaborations are expected as work continues ...
QGEN,QGEN:UW,BBG000GTZC67,CareDx and QIAGEN Enter Into Commercial Collaboration to Enhance HLA Lab Experience Using QIAxcel Instrumentation and CareDx HLA Typing Technology,2016-05-31 21:43:03 +0000,http://www.publicnow.com/view/408C566D8583F836E3ABAF0FD0DF94840EB4BCB9,"[at noodls] - 1a3bd874-14c8-424c-bf21-1e17552b28eb.pdf NEWS RELEASE Brisbane, CA-May 31, 2016-CareDx, Inc. (Nasdaq: CDNA), a global molecular diagnostics company focused on the discovery, development and commercialization ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN integrates quality control tools into GeneReader NGS System,2016-05-31 20:13:05 +0000,http://www.publicnow.com/view/29883B0302D12DCA42D402D70F74C5CDEEEDBAE9,"[at noodls] - Reference data set from Horizon affirms proven accuracy of GeneReader workflow Hilden, Germany, and Germantown, Maryland, May 31, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced ..."
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen, Therawis Diagnostics to Develop Breast Cancer Test",2016-05-27 14:12:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uhx_jGJkErE/qiagen-therawis-diagnostics-to-develop-breast-cancer-test-cm627403,"QiagenNVQGEN recently signed a licensing and co development agreement with Germany's Therawis Diagnostics GmbH to jointly develop and market predictive tests to detect cancer, particularly breast cancer.  With the global cancer diagnostic market expected to grow at a CAGR"
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Bioinformatics continues to set the standard with Hereditary Disease Solution,2016-05-23 15:36:05 +0000,http://www.publicnow.com/view/B925405AC71C9ABF689CD26E92C4C26852D5098A,"[at noodls] - Expanded offering provides highly accurate clinical sequence data interpretation Barcelona, Spain, May 19, 2016- QIAGEN today announced two milestones in its delivery of solutions for clinical analysis ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN Bioinformatics continues to set the standard with Hereditary Disease Solution,2016-05-23 15:36:05 +0000,http://www.publicnow.com/view/19B5CA98A51909ABACB9EDA4B40F5EDB8B62ACB6,"[at noodls] - Expanded offering provides highly accurate clinical sequence data interpretation Barcelona, Spain, May 19, 2016- QIAGEN today announced two milestones in its delivery of solutions for clinical analysis ..."
QGEN,QGEN:UW,BBG000GTZC67,QIAGEN extends tender offer period for acquisition of Exiqon A/S,2016-05-19 13:12:04 +0000,http://www.publicnow.com/view/1F51AE62F6286C198EF9F7725938FEC3091CBF24,"[at noodls] - Offer for DKK 18 per share remains valid until 2 June 2016 Venlo, The Netherlands, May 19, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the extension of the offer period ..."
QGEN,QGEN:UW,BBG000GTZC67,Qiagen NV Looks for a Strong Second Half,2016-05-04 01:44:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mBZZkJj3AR8/qiagen-nv-looks-for-a-strong-second-half-cm615830,"Qiagen released first quarter earnings on Thursday, with stagnant growth and investments cutting into the bottom line. The second half of the year looks to be more impressive, but let's take a look at the"
QGEN,QGEN:UW,BBG000GTZC67,"Qiagen (QGEN) Q1 Earnings Meet, Revenues Top; View Intact",2016-04-28 20:10:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5EsBnfYRwxM/qiagen-qgen-q1-earnings-meet-revenues-top-view-intact-cm613411,"QiagenNVQGEN reported first quarter 2016 adjusted earnings of 19 cents per share, which were in line with the Zacks Consensus Estimate. On a year over year basis, however, adjusted earnings declined 13.6%. At constant exchange rate or CER, the"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen meets 1Q profit forecasts,2016-04-27 20:49:39 +0000,http://sg.finance.yahoo.com/news/qiagen-meets-1q-profit-forecasts-204939892.html,Qiagen meets 1Q profit forecasts
QGEN,QGEN:UW,BBG000GTZC67,Ad hoc Announcement according to §15 WpHG,2016-04-27 20:27:42 +0000,http://www.publicnow.com/view/CFCAFA476C72059CDC62E166994EBD0F48CA472D,"[at noodls] - QIAGEN to conduct an up to US$100 million share repurchase program Venlo, The Netherlands,April 27, 2016 - QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has ..."
QGEN,QGEN:UW,BBG000GTZC67,Implied EQAL Analyst Target Price: $26,2016-03-28 12:26:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pXDcSZqnx9s/implied-eqal-analyst-target-price-26-cm597967,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
QGEN,QGEN:UW,BBG000GTZC67,Qiagen misses Street 3Q forecasts,2015-10-28 21:09:45 +0000,http://sg.finance.yahoo.com/news/qiagen-misses-street-3q-forecasts-210945315.html,Qiagen misses Street 3Q forecasts
QGEN,QGEN:UW,BBG000GTZC67,Qiagen misses Street 4Q forecasts,2015-01-28 22:27:42 +0000,http://sg.finance.yahoo.com/news/qiagen-misses-street-4q-forecasts-222742565.html,Qiagen misses Street 4Q forecasts
QGEN,QGEN:UW,BBG000GTZC67,Qiagen meets 3Q profit forecasts,2014-10-29 22:57:58 +0000,http://sg.finance.yahoo.com/news/qiagen-meets-3q-profit-forecasts-225758380--finance.html,Qiagen meets 3Q profit forecasts
QGEN,QGEN:UW,BBG000GTZC67,"AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests",2014-07-28 06:00:00 +0000,http://uk.finance.yahoo.com/news/astrazeneca-taps-roche-qiagen-blood-060000795.html,"AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests"
